Myocardial Phosphoproteomics and Single Cardiomyocyte Force Measurements Endorse Dyrk1A as a Candidate Therapeutic Target for Incomplete Myocardial Reverse Remodelling After Aortic Valve Replacement
AuthID
P-00Y-ZJE
P-00Y-ZJE